GlassScriptPhysician profile
Matthew Abrantes Costa
NPI 1275063562
$1,128.19
in general payments reported to CMS, 2019-2025
16 companies · $798 in 2025
The $798 reported for 2025 was more than what 88% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.10 · 2021: $18.35 · 2022: $210 · 2023: $86.12 · 2025: $798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $471.36 | 2025 | Creo, Excelsius Gps, Quartex |
| Zimmer Biomet Holdings, INC. | $104.39 | 2022-2025 | Gel-One Cross-Linked Hyaluronate |
| Trice Medical, INC. | $86.56 | 2022 | |
| Abbvie INC. | $77.94 | 2025 | |
| Abbott Laboratories | $71.66 | 2022-2025 | Eterna, Proclaim |
| Ferring Pharmaceuticals INC. | $48.68 | 2025 | Euflexxa |
| Merz Pharmaceuticals, LLC | $44.21 | 2025 | Xeomin |
| Saluda Medical Americas, INC. | $36.89 | 2025 | Evoke |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.34 | 2021-2022 | |
| Bioventus LLC | $29.08 | 2023 | Durolane |
| Nevro Corp. | $24.57 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $23.31 | 2025 | |
| Heraeus Medical, LLC. | $22.59 | 2023 | Palacos |
| Depuy Synthes Sales INC. | $18.21 | 2025 | Monovisc, Orthovisc |
| Synergy Orthopedics, LLC | $16.30 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $16.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Costa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.